Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
royalstreet.vc

Investments

54

Portfolio Exits

9

Funds

4

About Royal Street Ventures

Royal Street Ventures, formerly Royal Street Investment & Innovation Center, focuses on companies innovating in sectors that have become staid, brands providing new and real value to consumers, and entrepreneurs who share our passion for creating great businesses.

Headquarters Location

7620 Royal St East Suite 205

Park City, Utah, 84060,

United States

435-200-4930

Want to inform investors similar to Royal Street Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Royal Street Ventures

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Royal Street Ventures in 1 CB Insights research brief, most recently on Jun 24, 2020.

Latest Royal Street Ventures News

Curavit Raises $5M in Series A Funding

Nov 14, 2022

Curavit Clinical Research , a Boston, MA-based virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs), raised $5m in Series A funding. The round was led by Osage Venture Partners with participation from Royal Street Ventures and Narrow Gauge Ventures. It adds to early investments from founders and individual investors, including industry veterans Clark Golestani, former president of emerging businesses and global CIO of Merck, and former president and co-founder of Veeva Systems, Matt Wallach. The company intends to use the funds to expand DCT capabilities, partnerships, and market adoption of its virtual CRO services and platform for prescription and non-prescription digital therapeutics trials. Led by Joel Morse, co-founder and CEO, Curavit Clinical Research is a full-service, virtual contract research organization (VCRO), focused on designing and executing digital-first decentralized clinical trials (DCTs). Its digital-first DCTs improve timelines, reduce costs, yield real-world data, and increase patient access for therapies more effective across representative populations. FinSMEs

Royal Street Ventures Investments

54 Investments

Royal Street Ventures has made 54 investments. Their latest investment was in Curavit as part of their Series A on October 10, 2022.

CBI Logo

Royal Street Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/13/2022

Series A

Curavit

$5M

Yes

4

10/3/2022

Series A

Polco

$14M

Yes

5

3/25/2022

Series A

Salad Technologies

$17M

No

2

12/6/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

9/16/2021

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

10/13/2022

10/3/2022

3/25/2022

12/6/2021

9/16/2021

Round

Series A

Series A

Series A

Seed VC

Seed VC

Company

Curavit

Polco

Salad Technologies

Subscribe to see more

Subscribe to see more

Amount

$5M

$14M

$17M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

5

2

10

10

Royal Street Ventures Portfolio Exits

9 Portfolio Exits

Royal Street Ventures has 9 portfolio exits. Their latest portfolio exit was Trelora on December 12, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/12/2022

Acquired

$99M

8

9/22/2022

Merger

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/17/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/12/2022

9/22/2022

6/1/2022

12/17/2021

9/8/2020

Exit

Acquired

Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

8

10

10

10

10

Royal Street Ventures Fund History

4 Fund Histories

Royal Street Ventures has 4 funds, including Royal Street Ventures III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/4/2020

Royal Street Ventures III

$16.4M

1

1/2/2020

Royal Street Ventures Seed Fund III

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2016

Royal Street Ventures Seed Fund II

Subscribe to see more

Subscribe to see more

10

1/21/2016

Royal Street Ventures

$99M

10

Closing Date

1/4/2020

1/2/2020

12/31/2016

1/21/2016

Fund

Royal Street Ventures III

Royal Street Ventures Seed Fund III

Royal Street Ventures Seed Fund II

Royal Street Ventures

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$16.4M

$99M

$99M

Sources

1

10

10

10

Royal Street Ventures Team

2 Team Members

Royal Street Ventures has 2 team members, including current Managing Director, Laura Brady.

Name

Work History

Title

Status

Laura Brady

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Laura Brady

Subscribe to see more

Work History

Title

Managing Director

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.